tiprankstipranks
Trending News
More News >

Silence Therapeutics Passes Key Resolutions at AGM

Story Highlights
Silence Therapeutics Passes Key Resolutions at AGM

Don’t Miss TipRanks’ Half-Year Sale

Silence Therapeutics ( (SLN) ) just unveiled an announcement.

On June 26, 2025, Silence Therapeutics held its Annual General Meeting where all thirteen proposed resolutions were passed. Key decisions included the reappointment of directors, approval of executive compensation on an annual basis, and the ratification of PricewaterhouseCoopers LLP as auditors. These resolutions reflect the company’s strategic focus on governance and financial oversight, potentially strengthening its operational stability and stakeholder confidence.

The most recent analyst rating on (SLN) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Silence Therapeutics stock, see the SLN Stock Forecast page.

Spark’s Take on SLN Stock

According to Spark, TipRanks’ AI Analyst, SLN is a Neutral.

Silence Therapeutics is in a growth phase with positive technical momentum, but faces significant financial challenges with negative equity and poor valuation metrics. The stock’s technical strength is its primary asset, though it must address financial and valuation issues for long-term growth.

To see Spark’s full report on SLN stock, click here.

More about Silence Therapeutics

Silence Therapeutics plc operates in the biotechnology industry, focusing on developing RNA-based therapeutics. The company specializes in gene silencing technology, which aims to treat diseases by selectively inhibiting the expression of specific genes.

Average Trading Volume: 211,600

Technical Sentiment Signal: Sell

Current Market Cap: $273.9M

Learn more about SLN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1